JAKAVI
Drug
Novartis Pharma AG
Total Payments
$13,850
Transactions
8
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $13,850 | 8 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $13,200 | 2 | 95.3% |
| Travel and Lodging | $547.32 | 4 | 4.0% |
| Food and Beverage | $102.44 | 2 | 0.7% |
Ad
Manufacturing Companies
- Novartis Pharma AG $13,850
Product Information
- Type Drug
- Total Payments $13,850
- Total Doctors 2
- Transactions 8
About JAKAVI
JAKAVI is a drug associated with $13,850 in payments to 2 healthcare providers, recorded across 8 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2018 to 2018. In 2018, $13,850 was paid across 8 transactions to 2 doctors.
The most common payment nature for JAKAVI is "Consulting Fee" ($13,200, 95.3% of total).